<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2040">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05134610</url>
  </required_header>
  <id_info>
    <org_study_id>116736</org_study_id>
    <nct_id>NCT05134610</nct_id>
  </id_info>
  <brief_title>Effect of Perioperative OPEP Therapy on Post-operative Pulmonary Complications: a Pilot Study</brief_title>
  <official_title>Effectiveness of Perioperative Oscillating Positive Expiratory Pressure (OPEP) Therapy in Reduction of Post-operative Respiratory Morbidity in Patients Undergoing Colorectal Surgery: a Pilot Randomized Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Western University, Canada</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Western University, Canada</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      For patients undergoing colorectal surgery, post-operative pulmonary complications (PPCs) are&#xD;
      common. PPCs are associated with increased morbidity and mortality, as well as prolonged&#xD;
      hospital stays and healthcare costs. Pulmonary exercise in the pre-operative setting is&#xD;
      thought to improve pulmonary fitness and decrease incidence of PPCs. Use of an oscillating&#xD;
      positive expiratory pressure (OPEP) device sees patients improve their respiratory fitness&#xD;
      through prescribed usage of a handheld instrument that exercises pulmonary muscles while&#xD;
      breathing. Here, we propose a pilot randomized-controlled trial (RCT) to evaluate the&#xD;
      feasibility of a large scale study that would examine the effect of preoperative OPEP device&#xD;
      exercises in preventing PPCs for patients undergoing elective colorectal surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post operative pulmonary complications</measure>
    <time_frame>18 months</time_frame>
    <description>A composite outcome that includes atelectasis, pneumonia, prolonged requirement for supplemental oxygen, and respiratory failure together as a composite</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pulmonary Complication</condition>
  <condition>Surgery--Complications</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard of care for pre- and post-op pulmonary care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OPEP Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>14 days pre- and and post-op OPEP device usage</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AEROBIKA POSITIVE EXPIRATORY PRESSURE DEVICE</intervention_name>
    <description>Intervention arm patients use the OPEP device twice daily for 2 weeks before and after surgery</description>
    <arm_group_label>OPEP Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients must be 18 years of age or older, and scheduled for an elective colorectal&#xD;
             procedure at London Health Science Center (LHSC). Informed consent must be obtained.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients unable to perform written consent will be excluded. We will not include&#xD;
             colorectal procedures performed for urgent or emergent indications. Patients with&#xD;
             advanced pulmonary disease necessitating home oxygen pre-operatively will be excluded.&#xD;
             Patients that are pregnant will be excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jeff Metz, MD</last_name>
    <phone>4169533991</phone>
    <email>jeffmetz2@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nawar Alkhamesi, MD</last_name>
    <phone>1-519-663-3985</phone>
    <email>Nawar.Alkhamesi@lhsc.on.ca</email>
  </overall_contact_backup>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 14, 2021</study_first_submitted>
  <study_first_submitted_qc>November 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 26, 2021</study_first_posted>
  <last_update_submitted>November 14, 2021</last_update_submitted>
  <last_update_submitted_qc>November 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Western University, Canada</investigator_affiliation>
    <investigator_full_name>Nawar Alkhamesi MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>oscillating pulmonary expiratory pressure therapy</keyword>
  <keyword>OPEP</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

